Zhujiang Hospital,Southern Medical University
Welcome,         Profile    Billing    Logout  
 35 Trials 
13 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chen, Xin
TQB2450-III-09, NCT04964479: A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)

Recruiting
3
375
RoW
TQB2450 injection, Anlotinib Hydrochloride Capsules, Pembrolizumab injection, Placebo
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non Small Cell Lung Cancer
12/22
03/23
NCT05003245: Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD

Recruiting
3
388
RoW
HLX04-O,recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection, Lucentis
Shanghai Henlius Biotech
Age Related Macular Degeneration
08/23
03/24
NCT06301854: Long-term Safety of TPN171H Tablet in Erectile Dysfunction.

Recruiting
3
472
RoW
TPN171H, Simmerafil
Vigonvita Life Sciences
Erectile Dysfunction
04/25
04/25
NCT04937387: Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma

Completed
3
359
RoW
FF/VI, FF/UMEC/VI, ELLIPTA
GlaxoSmithKline
Asthma
08/24
08/24
PM8002-B004C-TNBC-R, NCT05918133: A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC

Recruiting
1/2
60
RoW
PM8002, nab-paclitaxel
Biotheus Inc.
TNBC
10/26
10/26
NCT05001412: Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC

Recruiting
1
36
RoW
Camrelizumab; apatinib; carboplatin; etoposide
Zhou Chengzhi, Jiangsu Hengrui Pharmaceutical Co., Ltd.
Extensive Stage Small Cell Lung Cancer
01/23
01/24
TLIF, NCT04073563: Transforaminal Lumbar Interbody Fusion

Recruiting
N/A
1017
US, RoW
Infuse™ Bone Graft (Infuse™), Intervertebral body fusion device and Medtronic posterior Fixation Systems
Medtronic Spinal and Biologics
Degenerative Disease of the Lumbosacral Spine
04/26
04/28

Active, not recruiting
N/A
255
RoW
EDWARDS INSPIRIS RESILIA Aortic Valve
Edwards Lifesciences, Edwards (Shanghai) Lifesciences Medical Supplies Co., Ltd., Rundo International Pharmaceutical Research & Development Co.,Ltd., Fuwai Hospital, CAMS & PUMC
Aortic Valve Replacement
12/28
12/29
Duan, Chuanzhi
EMPOWER, NCT04289480: Safety and Effectiveness of ENTERPRISE 2 Device in the Endovascular Treatment of Intracranial Aneurysms

Active, not recruiting
N/A
164
RoW
ENTERPRISE 2 device
Medos International SARL, Johnson & Johnson Medical (Shanghai) Ltd.
Intracranial Aneurysm
04/22
01/27
NCT05058482: Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations

Recruiting
N/A
116
RoW
embolism
Suzhou Hengruihongyuan Medical Technology Co. LTD
Intracranial Arteriovenous Malformations
10/23
10/24
NCT05898893: PARAT PLUS (The Tubridge Plus For The Treatment Of Wide-Necked Intracranial Aneurysms)

Recruiting
N/A
99
RoW
Microport NeuroTech Tubridge Plus flow-diverter Stent
MicroPort NeuroTech Co., Ltd.
Intracranial Aneurysm
03/24
12/24
NCT06479343: Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations

Recruiting
N/A
170
RoW
Liquid Embolic System (Tonbridge), Onyx Liquid Embolic System (Medtronic)
Zhuhai Tonbridge Medical Tech. Co., Ltd.
Intracranial Arteriovenous Malformations
10/25
10/26
NCT05755516: Efficacy and Safety of the Self-expanding Intracranial Stent (Tonbridge) for Endovascular Treatment of Intracranial Aneurysms

Active, not recruiting
N/A
204
RoW
Self-expanding Intracranial Stent (Tonbridge), LVIS and LVIS Jr. (MicroVention)
Zhuhai Tonbridge Medical Tech. Co., Ltd.
Intracranial Aneurysm
10/24
04/25
Yang, Pingzhen
No trials found
Guang, Sun Y
No trials found

Download Options